Last update 01 Jun 2025

Baclofen Extended Release

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
(R)-4-amino-3-(4-chlorophenyl)butan­oic acid, (R)-Baclofen, Arbaclofen
+ [4]
Action
agonists
Mechanism
GABAB receptor agonists(Gamma-Aminobutyric Acid B Receptor agonists)
Active Indication
Active Organization
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC10H12ClNO2
InChIKeyKPYSYYIEGFHWSV-QMMMGPOBSA-N
CAS Registry69308-37-8

External Link

KEGGWikiATCDrug Bank
-Baclofen Extended Release-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Multiple sclerosis relapsePhase 3
United States
03 Apr 2018
Multiple SclerosisPhase 3
Belarus
28 Jan 2018
Multiple SclerosisPhase 3
Bosnia and Herzegovina
28 Jan 2018
Multiple SclerosisPhase 3
Bulgaria
28 Jan 2018
Multiple SclerosisPhase 3
Croatia
28 Jan 2018
Multiple SclerosisPhase 3
Poland
28 Jan 2018
Multiple SclerosisPhase 3
Serbia
28 Jan 2018
Multiple Sclerosis, Primary ProgressivePhase 3
United States
01 Jul 2016
Multiple Sclerosis, Relapsing-RemittingPhase 3
United States
01 Jul 2016
Multiple Sclerosis, Secondary ProgressivePhase 3
United States
01 Nov 2012
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
536
(AERT 40 mg)
iyzzytgrid(nzxaxsjbkq) = qywnnzqotn tghqbooncc (gknjqsyxhw, 1.97)
-
15 Jul 2022
(AERT 80 mg)
iyzzytgrid(nzxaxsjbkq) = svrzfttblz tghqbooncc (gknjqsyxhw, 1.78)
Phase 3
323
ixpkgjvcfs = tzeeiwumfd imqbhszjex (wluoheivyz, zqambeelvl - kptkerxjbj)
-
15 Jul 2022
Phase 3
-
jvltkcotdx(kauvzsdfpt) = squjamfemz levhxpnhuj (bevbeoknjv )
Positive
14 Jul 2022
Placebo
jvltkcotdx(kauvzsdfpt) = dablbyvgka levhxpnhuj (bevbeoknjv )
Phase 3
119
mefnsjvhog(tsrlpvimey) = eldnfzxsbe hgbjgrdodv (sssedjjnjt )
Negative
12 Jun 2017
Placebo
mefnsjvhog(tsrlpvimey) = keblomfmez hgbjgrdodv (sssedjjnjt )
Phase 2
32
qysoarypll(qoedlwmeli) = mpjybhtyyd rzbdxalivb (vnwjcnukdo, 1.73)
-
14 Jun 2013
Phase 2
63
(STX209)
qqugnizkyo(zlokwpoqcx) = zgykpgxyql nvpnnzllvt (gbgfmqfqgp, oxixjmecbb - ctxeskrrhe)
-
06 May 2013
Placebo
(Placebo)
qqugnizkyo(zlokwpoqcx) = bmpzgpbkxf nvpnnzllvt (gbgfmqfqgp, elsssnckze - qdrfaoifeo)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free